Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients. [electronic resource]
Producer: 20060526Description: 253-9 p. digitalISSN:- 0340-6245
- Adult
- Aged
- Aged, 80 and over
- Arachidonic Acid -- pharmacology
- Aspirin -- blood
- Coronary Artery Disease -- drug therapy
- Cyclooxygenase 1 -- genetics
- Diabetes Mellitus -- drug therapy
- Female
- Genotype
- Humans
- Male
- Middle Aged
- Pharmacogenetics
- Platelet Aggregation -- drug effects
- Platelet Aggregation Inhibitors -- pharmacology
- Platelet Function Tests
- Platelet Membrane Glycoproteins -- genetics
- Polymorphism, Single Nucleotide
- Sex Factors
- Thromboxane B2 -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.